Table 4.
Cure rate by pathogen in the microbiologically evaluable population
| Speciesa | No. of subjects with indicated antibiotic test value/total no. of subjects (%) |
||
|---|---|---|---|
| Tigecycline (75 mg) | Tigecycline (100 mg) | Imipenem/cilastatin | |
| Acinetobacter calcoaceticus | 2/3 (66.7) | 1/2 (50.0) | 2/3 (66.7) |
| Enterobacteriaceaeb | 2/4 (50.0) | 3/4 (75.0) | 4/7 (57.1) |
| Haemophilus spp. | 1/1 (100.0) | 0/1 (0) | 0/1 (0) |
| Staphylococcus aureus | 6/8 (75.0) | 5/6 (83.3) | 8/9 (88.9) |
| MSSA | 3/4 (75.0) | 3/4 (75.0) | 4/5 (80.0) |
| MRSA | 3/4 (75.0) | 2/2 (100.0) | 4/4 (100.0) |
| Streptococcus spp.c | 3/3 (100.0) | 0/1 (0) | 1/1 (100.0) |
a
MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus.
b
Includes Enterobacter cloace, Escherichia coli, Klebsiella oxytoca, Klebsiella pneumoniae, and Serratia marcescens.
c
Includes Streptococcus mitis, Streptococcus oralis, and Streptococcus pneumoniae.